Sung Yong Oh

Quick facts

Phase 2 pipeline

• Docetaxel-PM · Oncology
  Docetaxel-PM is a taxane chemotherapy medication that works by inhibiting microtubule dynamics, thereby inducing apoptosis in cancer cells.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Sung Yong Oh portfolio CI brief
• Sung Yong Oh pipeline updates RSS